Bioceres Crop Solutions C...

NASDAQ: BIOX · Real-Time Price · USD
2.90
-0.10 (-3.33%)
At close: Aug 15, 2025, 10:04 AM

Bioceres Crop Solutions Income Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020
Revenue
59.6M 106.8M 92.6M 124.31M 84M 140.3M 116.18M 105.07M 92.98M 94.55M 126.84M 101.56M 68.23M 92.31M 66.35M 81.05M 35.54M 48M 42.11M
Cost of Revenue
36.12M 61.7M 55.38M 77.65M 41.4M 88.8M 72.65M 66.37M 36.63M 60.79M 75.41M 65.13M 44.57M 54.98M 37.33M 48.4M 20.22M 24.34M 22.86M
Gross Profit
23.47M 45.1M 37.22M 46.66M 42.6M 51.5M 43.53M 38.7M 56.36M 33.76M 51.43M 36.42M 23.66M 37.33M 29.02M 32.66M 15.32M 23.66M 19.24M
Operating Income
933.21K 7.9M 2.37M 9.48M 11.9M 16.8M 5.29M 5.11M 29.87M 2.22M 16.99M 9.98M 2.15M 17.7M 10.04M 13.71M 4.77M 11.53M 8.37M
Interest Income
n/a n/a n/a n/a 20.66K 29.95K n/a n/a n/a n/a 107.83K n/a n/a n/a n/a n/a n/a n/a 4.62K
Pretax Income
-5.6M 45.99K -6.4M -6.11M 7.9M 9.6M -2.25M -4.37M 22.29M -7.74M 8.92M 2.36M -2.64M 9.48M 4.86M 9.49M -233.81K 5.63M -4.36M
Net Income
-1.3M 100K -5.5M -1.53M 9.5M 108.45K -4.59M -1.71M 28.2M -8.16M 498.3K -5.01M -6.49M 3.43M 874.14K 633.69K -1.18M 648.19K -6.97M
Selling & General & Admin
21.01M 28.56M 21.13M 22.58M 30.7M 34.8M 26.75M 2.63M 23.99M 28.41M 24.95M 19.03M 18.03M 18.81M 12.5M 5.71M 10.21M 11.22M 8.2M
Research & Development
3.66M n/a n/a 5.37M 2.22M 2.2M 4.58M 4.14M 3.89M 3.46M 3.85M 2.3M 1.84M 1.38M 1.43M 2.04M 1.44M 1.11M 1.02M
Other Expenses
-2.13M 37.2M n/a 5.16M -142.35K n/a -1.47M -159.06K -22.1K n/a n/a -163.34K n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
22.54M 37.2M 34.87M 36.59M 30.7M 36.7M 39.39M 32.21M 26.87M 31.58M 35.12M 26.69M 21.31M 20.77M 18.56M 18.18M 11.45M 12.2M 11.01M
Interest Expense
6.16M 7.43M 6.2M 7.21M 4.4M 7.3M 7.03M 5.76M n/a 9.96M 5.72M 4.9M n/a 8.22M 2.55M 5.26M 4.48M 5.37M 4.8M
Selling & Marketing Expenses
4.14M 850.01K 3.9M 4.06M 1.13M 1.14M 4.94M 1.16M 1.29M 1.36M 5.99M 4.74M 1.3M 1.27M 3.67M 847.05K 608.35K 600.23K 1.62M
Cost & Expenses
58.66M 98.9M 90.25M 114.83M 72.1M 125.5M 112.04M 98.58M 63.5M 92.37M 110.54M 91.83M 65.88M 75.75M 55.89M 66.57M 31.67M 36.54M 33.88M
Income Tax Expense
-4.01M -200K -1.2M -4.03M -1M 8.3M 429.04K -1.58M -5.19M 684.91K 5.01M 6.9M 4.34M 4.14M 2.6M 8.12M 390.71K 3.84M 2.01M
Shares Outstanding (Basic)
62.8M 62.82M 62.85M 60.59M 62.8M 62.84M 62.85M 62.8M 62M 61.66M 60.54M 45.87M 41.14M 41.1M 41.1M 40.64M 38.76M 38.02M 36.37M
Shares Outstanding (Diluted)
62.8M 63.2M 62.9M 60.59M 66.8M 63.88M 62.85M 62.8M 63.08M 61.66M 61.74M 45.87M 41.14M 42.4M 42.38M 41.1M 38.76M 39.04M 36.37M
EPS (Basic)
-0.02 0.00 -0.09 -0.03 0.15 0.00 -0.07 -0.03 0.45 -0.13 0.01 -0.11 -0.16 0.08 0.02 0.02 -0.03 0.02 -0.19
EPS (Diluted)
-0.02 0.00 -0.09 -0.03 0.14 0.00 -0.07 -0.03 0.45 -0.13 0.01 -0.11 -0.16 0.08 0.02 0.02 -0.03 0.02 -0.19
EBITDA
6.63M 13.37M 5.2M 9.08M 16.22M 16.25M 9.61M 5.87M 34.48M 3.43M 19.4M 11.27M 4.04M 19.39M 10.28M 17.85M 5.64M 12.24M 1.83M
EBIT
559.23K 7.4M -1.3M 1.1M 12.29M 13.39M 4.78M 1.46M 29.49M -1.98M 14.64M 7.75M 2.91M 17.7M 7.41M 14.76M 3.87M 11M 440.1K
Depreciation & Amortization
6.07M 5.89M 5.31M 6.61M 400K -2M 4.83M 4.41M 4.99M 5.45M 4.54M 3.52M 2.12M 1.69M 1.86M 2.03M 1.77M 1.31M 1.16M